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ABSTRACT
Objective: Doxorubicin (Dox), an anthracycline antibiotic, has been widely used to treat cancer, principally hematological malignancies, and solid 
tumors. The administration of Dox is a topic of concern in the medical community, as it frequently related to dose-dependent cardiotoxicity. Therefore, 
the present study was designed to investigate the protective potential of date palm fruit extract on Dox-induced cardiotoxicity.
Methods: A total of 40 female albino rats were used in this study and classified into four groups including control, date palm fruit extract, Dox, and 
treated date palm fruit extract groups.
Results: Dox produced a significant increase in creatine kinase-MB and lactate dehydrogenase activities. It also decreased the activities of cardiac 
glutathione peroxidase and superoxide dismutase but increase levels of cardiac malondialdehyde and also of urinary 8-hydroxy-2-deoxyguanosine. 
Myocardial toxicity of Dox also appeared in the elevation of serum total cholesterol, triglycerides, and low-density lipoprotein cholesterol levels, while 
level of high-density lipoprotein cholesterol decreased. Histopathological studies revealed alteration of cardiac tissue structure by Dox. Treatment 
with date palm fruit extract restored the aforementioned parameters.
Conclusion: Date palm fruit exhibits a cardioprotective influence on the heart tissue against toxicity induced by Dox.
Keywords: Phoenix dactylifera L., Cardioprotective, Doxorubicin, Cardiotoxicity, 8-hydroxy-2-deoxyguanosine, High-performance liquid 
chromatography.
INTRODUCTION
In parallel with the increase in the number of confirmed cases of 
cancer, new modalities of treatment have increased cancer survival and 
possibilities of cure. However, the treatment may cause several adverse 
effects including treatment-related cardiotoxicity that may lead to poorer 
prognosis than cancer itself, and also affect treatment continuation [1,2].
Patients with malignant neoplasm may have underlying cardiovascular 
diseases, the consequences of which are often exacerbated by the 
tumor growth stress or its treatment. With the start of new treatments 
and consequent extended survival time, late effects of cancer treatment 
can become clinically manifest decades after completion of therapy. 
The heart’s extensive energy reserve and its ability to compensate for 
reduced function increase the complexity of diagnosis and initiation 
of therapy. Treatment-related impairment of cardiac contractility may 
be reversible or irreversible. In addition, the treatment of cancer is 
well associated with life-threatening arrhythmia, infarction, ischemia, 
and damage to the conduction system and cardiac valves. Knowledge 
of these processes has gained importance to give us an idea about 
strategies to prevent and monitor cardiovascular damage [3].
The principle for the study of how cancer and/or its treatment could 
affect the heart resulting from the observations that anthracyclines 
caused progressive heart failure which is dose-dependent and may 
cause cardiac death [3,4].
Antitumor anthracyclines such as doxorubicin (Dox), idarubicin, 
daunorubicin, and epirubicin are broadly used to treat hematologic 
malignancies and solid tumors; on the other hand, the clinical apply of 
anthracyclines is very limited due to their severe cardiotoxicity, which 
correlates with the cumulative administered dose [5,6].
It has been found that Dox stimulates free radicals that cause cell 
damage through entering into cardiomyocytes by passive diffusion. In 
addition, Dox inhibits gene transcription, mitochondrial function, and 
energy production by direct or indirect mechanisms [7,8].
Cardiotoxicity is responsible for free radicals production, enzymatic 
and non-enzymatic pathways, and redox-related damage caused by 
iron accumulation. In addition, it has been suggested that negative 
disturbance of the balance between antioxidant systems and free 
radicals is the main factor of cardiotoxicity [9].
In this respect, two pathways proposed for free radical generation by 
Dox [10]; the first mechanism is that Dox accepts an electron generated 
in the reaction catalyzed by flavoprotein enzymes and is converted to 
a reactive semiquinone form, which then spontaneously reacts with 
molecular oxygen producing a superoxide anion. The second mechanism 
is the non-enzymatic formation of a Dox-Fe2+ free radical complex, 
which then reacts with hydrogen peroxide (H2O2) resulting in hydroxyl 
radicals formation. These reactive oxygen species (ROS) react with 
proteins, nucleic acids, lipids, and other cellular constituents causing 
diverse oxidative damage to the cell membrane and mitochondria in 
heart muscle cells [11-13].
Date palm tree (Phoenix dactylifera L.) is well thought out as one of 
the main ancient and staple crops in North Africa and Southwest Asia. 
Moreover, dates grown in Southern Africa, Australia, South America, 
Mexico, and the United States, especially in Southern California, Texas, 
and Arizona [14,15].
Date palm fruit has been reported to be a good source of high nutritional 
value food. In fact, it is rich in carbohydrates, proteins, dietary fibers, 
minerals, and vitamin B complex, such as thiamine (B1), riboflavin 
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(B2), niacin (B3), pantothenic (B5), pyridoxine (B6), and folate 
(B9) [16]. Besides, it regarded as a good source of antioxidant vitamins 
A, C, and E. The anthocyanins, isoquercetrin, quercetin, quercetrin, 
procyanidins, apigenin, luteolin, and rutin constitute the flavonoid 
content of date palm fruit [17].
Numerous studies that have been conducted in the past four decades 
proposed that date palm fruits have varied medical apply such as 
anti-inflammatory, antihyperlipidemic, anticancer, gastroprotective, 
hepatoprotective, and nephroprotective activities and thus serving as a 
vital healthy food in the human diet [18].
In accordance with the aforementioned medicinal properties of date 
palm fruit, the present research has been designed to investigate the 




Oncodox - 50 mg vial (Doxorubicin hydrochloride USP, Mfd. by CIPLA 
LTD., INDIA) was purchased from local pharmacy. 8-hydroxyguanosine 
standard (high-performance liquid chromatography [HPLC] grade) was 
purchased from Sigma-Aldrich Company, ST. Louis, MO, USA.
Plants
Date fruits (P. dactylifera L. Palmae) Zaghlool were purchased from local 
market, Egypt.
Experimental animals
Female albino rats (Laboratory Animal Colony, National Research Centre, 
Cairo, Egypt) weighing 120–140 g were used in this study. Animals 
were housed in stainless steel community cages at 25±2°C, 12 h light/
dark cycle and allowed to acclimatize for 7 days before experimental 
use. Throughout the experiment, the rats were allowed free access 
feed (rats dietary pellets prepared by Cairo Company of Oil and Soap, 
Egypt) and water. The experiment was carried out in accordance with 
the Research Ethics Committee for Animal Subject Research at National 
Hepatology & Tropical Medicine Research Institute (NHTMRI – IRB) 
Cairo, Egypt.(serial:10-2018).
Plant extraction
About 500 g of edible portion of date fruits have been cutted into small 
pieces and extracted with 1 L of aqueous methanol (70%) by soaking 
for about 4 days at room temperature. The alcoholic extract was 
concentrated under reduced pressure using rotaevaporator (Heidolph, 
Hei-VAP series, GmbH and Co. KG in Schwabach, Germany). The used 
dose was (4 ml/kg b.w.) according to Vayalil [19].
Induction of cardiotoxicity
Dox was dissolved in 0.9% saline immediately before use, protected 
from light and given intraperitoneally (I.P) at a dose of 15 mg/kg b.w. 
before 48 h of blood sampling according to Chabner et al. [20].
Experimental design
A total of 40 female albino rats were used and divided into four groups 
(10 rats in each group) as follows:
Group I (control group): Healthy rats served as control group and 
received a vehicle.
Group II (date group): Healthy rats received date palm fruit extract 
(4 ml/kg b.w./day orally) for 30 days [19].
Group III (Dox group): Healthy rats received a vehicle and then received 
a single dose of Dox (15 mg/kg b.w., i.p.) at the end of experimental 
period [20].
Group IV (treated group): Healthy rats received date palm fruit extract 
(4 ml/kg b.w./day orally) for 30 days and then received a single dose of 
Dox (15 mg/kg b.w., i.p.).
At the end of the experimental period (30 days), animals were kept 
in metabolic individual cages for collection of 24 h urine samples for 
estimation of urinary 8-hydroxyguanosine.
Blood sampling
After the experimental period, rats were anesthetized using diethyl 
ether by inhalation then fasting blood samples were withdrawn from the 
retro-orbital venous plexus of the eye using capillary tubes, according 
to the method of Madway et al. [21]. Blood samples were collected in 
dry tube, left to clot, and serum was separated by centrifugation at 
3000 rpm using cooling centrifuge (Laborzentrifuge, 2K15, Sigma, 
Germany) for 15 min; samples were divided into aliquots and stored at 
−20°C for biochemical assays.
After blood samples were obtained, rats were decapitated, and heart 
tissues were separated and prepared for histopathological examination 
by routine light microscopic methods.
Preparation of tissue homogenate
Heart tissues were cutted into small pieces and homogenized in 5 ml 
cold buffer (0.5 g of Na2HPO4 and 0.7 g of NaH2PO4 per 500 ml deionized 
water [pH 7.4]) per g tissue, then centrifuged at 4000 rpm for 15 min 
at 4°C. Supernatant was then separated and used for estimation of 
oxidant/antioxidant parameters [22].
Biochemical assays
Biochemical markers of cardiotoxicity
Serum creatine kinase-MB (CK-MB) and lactate dehydrogenase (LDH) 
activities were determined using automated cobas c 311 system (Roche 
Diagnostics, Mannheim, Germany).
Lipid profile 
Serum triglycerides (TGs) were determined by glycerol-phosphate-
oxidase method as described by Jacobs and Vandemark [23]. Serum 
total cholesterol (TC) was determined using enzymatic method of 
Allain et al. [24]. Serum high-density lipoprotein cholesterol (HDL-C) 
was determined according to the method described by Fruchart 
et al. [25]. Dependently low-density lipoprotein cholesterol (LDL-C) 
was calculated by the Friedewald formula [26].
Oxidant and antioxidant profile
Cardiac glutathione peroxidase (GPx) and superoxide dismutase (SOD) 
activities were assayed by the method of Pagalia and Valentine [27] and 
Nishikimi et al. [28], respectively. Cardiac malondialdehyde (MDA) was 
determined according to Ohkawa et al. [29].
Determination of urinary 8-hydroxy-2-deoxyguanosine (8-OHdG) 
using HPLC
8-OHdG was estimated by HPLC system, Agilent technologies 1100 
series, equipped with a quaternary pump (Quat Pump, G131A model) 
according to Kim et al. [30] modified by Hussein et al. [31].
Standard preparation
For stock preparation, 1 mg standard was dissolved in 1 ml ultrapure 
water, and several dilutions were prepared, 20 µl from serial dilutions 
of standard was injected onto HPLC to draw a standard curve with 
different concentrations.
Sample extraction
8-OHdG was extracted from 1 ml urine. The eluents were dried under 
N2 stream, reconstituted in 5 ml ultrapure water, and filtered by PVDF 
0.45 μm filter. 20 µl from each sample was injected onto HPLC.
HPLC condition
The mobile phase was consisted of acetonitrile/methanol/phosphate 
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buffer (25/10/965) v/v, respectively. Phosphate buffer was prepared 
by dissolving 8.8 g of potassium dihydrogen phosphate in 1000 ml 
ultrapure water and pH was adjusted at 3.0; the buffer was then 
filtered 2 times through sterile membrane filters (47 mm Diam, pore 
size 0.45 μm) before being used at a flow rate of 1 ml/min through C18 
column (250×4.6, particle size 5 μm) using electrochemical detector 
with cell potential of 600 mV.
Calculation
The concentration of urinary 8-OHdG was calculated from the standard 
curve and divided on the urinary creatinine. Urinary creatinine was 
estimated by kinetic method as described by Larsen [32].
Histopathological examination of heart
Heart tissue was obtained from all experimental groups, washed 
immediately with saline and then fixed in 10% buffered neutral formalin 
solution. After fixation, the heart tissue processed by embedding in 
paraffin. Then, the heart tissue sectioned and stained with hematoxylin 
and eosin and examined under high power microscope (100×) [33].
Statistical analysis
All results were expressed as mean ± standard error; data were 
analyzed by one-way analysis of variance [34] by means of SPSS 
statistical software (version 17) followed by LSD test to compare 
significance between groups. Difference was considered statistically 
significant when p≤0.05.
RESULTS AND DISCUSSION
Dox, a member of anthracycline antibiotic class, is recognized as one of 
the most effective and widely used chemotherapeutic therapy for the 
treatment of a wide range of human cancers. However, clinical use of 
Dox is severely limited due to its significant cardiotoxic effects, which 
frequently resulting in the development of irreversible degenerative 
cardiomyopathy and ultimately heart failure [35,36].
Although numerous mechanisms have been proposed, most studies 
supported the increase in oxidative stress, along with reductions in 
the levels of antioxidants, which play a key role in the pathogenesis 
of Dox-induced cardiomyopathy. Consequently, the addition of natural 
or synthetic antioxidants to anticancer therapy may guard against the 
oxidative stress induced by Dox and other cytotoxic drugs [37]. Fruits 
and vegetables have been associated with decreased risks of several 
chronic diseases, involving oxidative stress and inflammation [38].
Date palm is one of the ancient trees cultivated from 6000 years. The 
different parts of date palm fruit are commonly used in traditional 
medicine to treat various disorders [18,39].
It has been demonstrated by several phytochemical studies that date 
palm fruits contain anthocyanins, sterols, carotenoids, phenolics, and 
procyanidins compounds which contribute to the numerous biological 
effects of date palm fruit as free radical scavenging, antioxidant, 
antimicrobial, antimutagenic, and immunostimulant activities [18,40].
The present work has been planned to explore the ability of date palm 
fruit extract in protection against cardiotoxicity induced by Dox in rats.
Cardiotoxicity induced by Dox is due to destruction of myocardial cells. 
This can lead to leakage of CK-MB and LDH into the circulation and serve 
as the diagnostic markers of myocardial injury. Therefore, the alteration 
in plasma membrane integrity and/or permeability is reflected by 
amount of these cellular enzymes in the bloodstream [41,42].
In this study, we observed that Dox treatment resulted in significant 
increase in both serum cardiac enzymes LDH and CK-MB activities. These 
results are in agreement with those reported by Argun et al. [8] and 
QuanJun et al. [43]. Whereas, the treatment by date palm fruit extract 
significantly decreases the mean values of serum CK-MB and LDH in 
compared to Dox group indicating its strong cardioprotective efficacy 
against Dox toxicity (Table 1).
El Arem et al. [44] reported that administration of date palm fruit 
extract restored the hepatic damage stimulated by trichloroacetic 
acid as confirmed by amelioration of LDH activity. Findings of the 
research by Abdalla et al. [40] reveal that treatment with dietary dates 
significantly reduced the increased activities of CK-MB and LDH. In a 
study performed by Daoud et al. [45], to evaluate the protective effect 
of date palm pollen (DPP) ethanolic extract on isoproterenol-induced 
myocardial infarction, pre-co-treatment with DPP extract enhanced 
the cardiac biomarkers injury, creatine phosphokinase, alanine 
aminotransferase, LDH, and troponin-T.
Administration of Dox to rats significantly increases the levels of serum 
TC, TG, and LDL-C but significantly decreases serum level of HDL-C 
compared to control (Table 2). These results were coincided with 
Dhana et al. [46] and Mansouri et al. [47].
These variations in the profile of lipid show that there is a possible 
interference of Dox with metabolism or biosynthesis of lipids [48,49]. 
Dox administration may lower the level of cytochrome P 450 which then 
depresses activity of cholesterol 7-hydroxylase, the enzyme responsible 
for the conversion of cholesterol to bile acids [50].
The results revealed that consumption of date palm fruit exerts a lipid-
lowering effect by inducing a significant decrease in serum levels of TC 
and LDL-C but insignificantly decrease serum level of TG. Even as there 
was insignificant increase in serum HDL-C compared to Dox group 
(Table 2).
These findings were in agreement with previous studies of Alsaif 
et al. [51] and Hasan et al. [52] who reported that the supplementation 
with date palm fruit reduced the concentrations of TC, TG, and LDL-C 
while caused elevation in levels of HDL-C in hypercholesterolemic 
hamsters and rabbit, respectively. In addition, date palm fruit extract 
treatment improved the changes in lipid profile in mice infected with 
the Eimeria papillata [53].
Dox and other antitumor anthracyclines have a tetracyclic quinone-
hydroquinone moiety, an aminosugar (daunosamine) and a short 
side chain with a carbonyl group. The quinone moiety is converted 
into a semiquinone radical by reduction of one electron. The parent 
quinone is then rapidly regenerated by reduction of molecular oxygen 
to superoxide anion and then dismutation of the latter produce H2O2. 
Therefore, the persistent redox cycling of the quinone moiety exposes 
Table 1: CK-MB and LDH in different studied groups





% changea −11.1% −2.3 %
% changeb −34.3% −28.1%
Dox
Mean±SE 769±42.7a 1253±30.4a
% changea 35.3 % 35.9%
Treated
Mean±SE 657±47b 911±38 b
% changea 15.6% −1.2 %
% changeb −14.5% −27.3%
Results are expressed as mean±SE, n=10. aSignificant difference at P≤0.05 as 
compared to control group. bSignificant difference at P≤0.05 as compared to 
Dox group. % changea: % of change from control group. % changeb: % of change 
from Dox group. CK-MB: Creatine kinase-MB, LDH: Lactate dehydrogenase, 
Dox: Doxorubicin, SE: Standard error
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cardiomyocytes to ROS that, in concert with iron, may lead to oxidative 
stress [6].
ROS can receive electrons from the lipids in cell membranes, resulting 
in lipid peroxidation which contributes to oxidant-induced cell death. 
MDA, a major and constant final product of peroxidation, is known as 
a commonly marker of lipid peroxidation [54]. Besides, ROS can cause 
structural and functional damage of mitochondria, which may result in 
cardiomyocytes apoptosis or death [55].
Cells have evolved different antioxidants to neutralize ROS which can 
suppress lipid peroxidation; so they are extremely vital for inhibiting 
oxidative stress-induced cytotoxicity. Antioxidant enzymes such as SOD, 
GPx, and catalase are capable of inhibiting the oxidation so that they 
are the major intracellular antioxidant defenses system. Consequently, 
overexpression of antioxidant enzymes can provide protective effects 
against the cardiomyocytes damage induced by ROS [56].
The reduction in myocardial antioxidant enzyme (SOD and GPx) 
activities in Dox group has been observed in this study. In addition, 
cardiotoxicity was further confirmed by increase in the cardiac MDA 
concentrations compared to the control group (Table 3). These results 
are consistent with the previous study reported by Chen et al. [57]. 
While date palm fruit extract, administration restored the cardiotoxicity 
induced by Dox as showed by amelioration of cardiac SOD, GPx activities, 
and cardiac MDA level.
These results were in agreement with Saafi et al. [58] who studied the 
hepatoprotective effect of date palm fruit extract on dimethoate-induced 
oxidative stress, and also with El-Gazzar et al. [59] who reported that 
pretreatment with Siwa date palm fruit extract ameliorated the elevation 
in hepatic MDA level induced by carbon tetrachloride (CCL4). In addition, 
activity of SOD increased toward the normal value by administration of 
hydromethanolic extract of date palm fruit in CCL4-intoxicated rats [60].
Feeding animals with dietary date palm fruit have been found to 
decrease the level of cardiac MDA and induce an enhancement in cardiac 
SOD and glutathione activities in a study by Abdalla et al. [40] planned 
to assess cardiac remodeling by dietary dates in Dox-intoxicated rats.
Under normal conditions, the free radicals attack nuclear and 
mitochondrial deoxyribonucleic acid (DNA), causing mutagenic DNA 
lesions; one of these lesions is 8-OHdG, which is the end product of 
guanine hydroxylation. The DNA lesions are, hence, removed by the base 
excision repair (BER) pathway, which prevents DNA lesions replication. 
However, ROS can inhibit BER which may potentiate mutagenesis and 
DNA damage [61,62].
Increased levels of 8-OHdG, an indicator of oxidative DNA damage, have 
been indicated in a variety of pathophysiological processes such as 
aging, carcinogenesis, degenerative and cardiovascular diseases [63,64], 
liver injury [65], and diabetes [31]. It has been reported that Dox able 
to generate 8-OHdG in human promyelocytic leukemia cells and MCF-7 
breast cancer cells [66,67].
Table 2: Lipid profile in different studied groups
Groups Total cholesterol (mg/dl) Triglycerides (mg/dl) HDL (mg/dl) LDL (mg/dl)
Control
Mean±SE 85±2.27 71.3± 2.63 38.8±0.85 31.5±2.7
Date
Mean±SE 89.6±4.56 b 69±2.61b 40.78±1.0b 36.8±3.7b
% changea 5.4% −3.2% 5.1% 16.8%
% changeb −18 % −26 % 25.2% −41.4%
Dox
Mean±SE 110.6±2.97a 93.3±4.63a 32.5±2.5a 62.8±3.7a
% changea 30% 30.8 % −16.2% 99.3%
Treated
Mean±SE 99.5±3.51a, b 85.5±3.62 a 36.2±2.0 44.7±4.6a, b
% changea 17% 19.9% −6.7% 41.9%
% changeb −10% −8.36% 11.4% −28.8%
Results are expressed as mean±SE, n=10. aSignificant difference at p≤0.05 as compared to control group. bSignificant difference at p≤0.05 as compared to Dox 
group. % changea: % of change from control group. % changeb: % of change from Dox group. Dox: Doxorubicin, SE: Standard error, HDL: High-density lipoprotein, 
LDL: Low-density lipoprotein
Table 3: Oxidant/antioxidant parameters in different studied groups
Groups GPx (U/g tissue) SOD (U/g tissue) MDA (nmol/g tissue) 8-OHdG (ng/mg creatinine)
Control
Mean±SE 4.2±0.5 303.3±5.4 30.8±7.5 5.1±0.17
Date
Mean±SE 4.7±1.0b 315.17±3.5b 21.1±3.8b 4.9±0.12b 
% changea 11.9% 4.09% −31.5% −2.7%
% changeb 90% 13.44% −47.5% −46%
Dox
Mean±SE 2.47±0.23 278.2±8.9a 40.2±6.4 9.2±0.29a
% changea −41.2% −8.2% 30.5% 80.4%
Treated
Mean±SE 3.6±0.5 299.17±6.6b 32.0±3.5 6.1±0.12a,b
% changea −14.3% −1.36% 3.9% 19.6% 
% changeb 45.7% 7.5% −20.4% −33.7%
Results are expressed as mean±SE, n=10. aSignificant difference at p≤0.05 as compared to control group. bSignificant difference at p≤0.05 as compared to Dox group. % 
changea: % of change from control group. % changeb: % of change from Dox group. Dox: Doxorubicin, SE: Standard error, GPx: Glutathione peroxidase, SOD: Superoxide 
dismutase, MDA: Malondialdehyde, 8-OHdG: 8-hydroxy-2-deoxyguanosine
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It has been observed in the present investigation that administration of 
Dox to rats significantly increase levels of urinary 8-OHdG.While pre-
treatment with date palm fruit extract has been shown to significantly 
decrease levels of urinary 8-OHdG. 
Histological examination of sections from control group illustrated 
normal characteristic features of myocardium with no cellular 
infiltration and normal vasculature. Myocardium is striated with 
branching, and the nucleus is located centrally. Occasionally, 
myocardium is binucleated. Intercalated discs between cardiac cells 
are seen (Fig. 1a). Normal myocardial features similar to that of normal 
control group were shown in date palm fruit group (Fig. 1b).
In this investigation, typical histopathological alterations such as 
interstitial edema between irregular wavy-directed cardiomyocytes, 
vascular dilatation and congestion, mild inflammatory cellular 
infiltration and fibrosis and myofibrolysis have been observed 
following Dox administration (Fig. 1c). This coincided with the work of 
the previous studies [68,69].
QuanJun et al. [43] found that Dox treatment resulted in chronic 
focal inflammatory pathology in the myocardium. This inflammatory 
infiltrate reflects the replacement of degenerated myocardial muscle 
fibers with plasma cells and lymphocytes.
In contrast, microscopic examination of sections from the heart of date 
palm fruit extract treated rats showed myocardial that appeared more 
or less like normal one (Fig. 1d). The histopathological examinations 
of a study by Abdalla et al. [40] showed that the distorted architecture 
of the cardiomyocytes induced by Dox has been restored by feeding 
animals with the dietary date palm fruits.
CONCLUSION
Date palm fruit extract administration protects against Dox-induced 
myocardial toxicity by reducing cardiac injury markers, reestablishment 
of oxidant/antioxidant parameters, ameliorating lipid profile, and 
lessening the histopathological changes. These effects may be due to 
its high contents of flavonoid (anthocyanins, apigenin, isoquercetrin, 
quercetin, quercitrin, procyanidins, luteolin, and rutin) and its lipid 
lowering effects.
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